The influence of hydro-alcoholic media on hypromellose matrix systems

Drug Development and Industrial Pharmacy

Volumn 33, Issue 10, 2007, Pages 1125-1134

  Levina, Marina ^a   Vuong, Hue ^a   Rajabi Siahboomi, Ali R ^a  

^a Colorcon Limited ^*  (United Kingdom)

Author keywords

Extended release; Felodipine; Gliclazide; HPMC; Hydroalcoholic; Hypromellose; Metformin HCl

Indexed keywords

AEROSIL; ALCOHOL; FELODIPINE; GLICLAZIDE; HYDROXYPROPYLMETHYLCELLULOSE; METFORMIN; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HYDRATION; VISCOSITY;

DELAYED-ACTION PREPARATIONS; ETHANOL; FELODIPINE; GLICLAZIDE; METHYLCELLULOSE; SOLUBILITY; TABLETS;

EID: 35649003947     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701377862     Document Type: Article

References (36)

1. Alderman, D. A. (1984). A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Tech. Prod. Mfr., 5, 1-9.
2. Bettini, R., Colombo, P., Massimo, G., Gatellani, P. L., & Vitali, T. (1994). Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci, 2, 213-219.
3. Campos-Aldrete, M. E., & Vallafuerte-Robles, L. (1997). Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm., 43, 173-178.
4. Colombo, P., Bettini, R., Santi, P., & Peppas N. A. (2000). Swelling matrices for controlled drug delivery: behaviour, mechanisms and optimal performance. Pharm. Sci. Tech. Today, 3(6), 198-204.
5. Doherty, C., & York, P. (1989) Microenvironmental pH control of drug dissolution. Int. J. Pharm., 50, 223-232.
6. Espinoza, R., Hong, E., & Villafuerte, L. (2000). Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int J Pharm., 201, 165-173.
7. Fadda, H., ALBasarah, Y., & Basit, A. (2006). Impairment of modified release formulations by alcohol in dissolution media and influence on drug release. AAPS Annual Meeting and Exposition, San Antonio, TX, USA.
8. Federal Register. (1995). Food and Drug Administration, Volume 60, No. 230, p. 61642.
9. FDA. (2005, July). FDA alert for healthcare professionals. Hydromorphone hydrochloride extended-release capsules (marketed as Palladone™), Alcohol-Palladone™ interaction.
10. Ford, J. L., Mitchell, K., Rowe, P., Armstrong, D. J., Elliott, P. N. C., Rostron, C., & Hogan, J. E. (1991). Mathematical modelling of drug release from hydroxypropylmethylcellulose matrices: Effect of temperature. Int J Pharm., 71, 95-104.
11. Ford, J. L., Rubinstein, M. H., & Hogan, J. E. (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices. Int. J. Pharm., 24, 327-338.
12. Ford, J. L., Rubinstein, M. H., McCaul, F., Hogan, J. E., & Edgar, P. J. (1987). Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methylcellulose matrix tablets, Int. J. Pharm., 40, 223-234.
13. IMS data. 2002.
14. Johnson, J. L., Holinej, J., & Williams, M. D. (1993). Influence of ionic strength on matrix integrity and drug release from hydroxypropylcellulose compacts. Int. J. Pharm., 90, 151-159.
15. Kavanagh, N., & Corrigan, O. I. (2004). Swelling and erosion properties of hydroxypropylmethylcellulose (hypromellose) matrices - Influence of agitation rate and dissolution medium composition. Int. J. Pharm., 279, 141-152.
16. Koziara, J., So, J., & Agarwal, N. (2006). The effect of ethanol on semipermeable cellulose acetate-based membranes. AAPS Annual Meeting and Exposition, San Antonio, TX, USA.
17. Lapidus, H., & Lordi, N. G. (1968). Drug release from compressed hydrophilic matrices. J. Pharm. Sci., 57(8), 1292-1301.
18. Levina, M., Gothoskar, A., & Rajabi-Siahboomi, A. R. (2006). Application of a modeling system in the formulation of extended release hydrophilic matrices. Pharm. Tech. Eur., 18(7), 20-26.
19. Li, C. L., Martini, L. G., Ford, J. L., & Roberts, M. (2005). The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol., 57(5), 533-546.
20. Longer, M. A., & Robinson, J. R. (1990). Sustained-release drug delivery systems. In A.R. Gennaro (Ed.) Remington's pharmaceutical sciences (pp. 1676-1693). PA, USA: Mack Publishing.
21. Martindale (1999). K. Parfitt (Ed.) London, UK: Pharmaceutical Press, pp. 320, 330, 867, 1100.
22. Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., & Hogan, J.E. (1990). The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrices. Int. J. Pharm., 66, 233-242.
23. Moore, J. W., & Flanner, H. H. (1996). Mathematical Comparison of Dissolution Profile. Pharm. Tech., 20(6), 64-74.
24. Pagay S. N. (1988). Use of buffers in matrix capsule formulations. Drug Dev. Ind. Phar., 14, 875-894.
25. rd Assoc. UK APS Conf., 21.
26. Rajabi-Siahboomi, A. R., & Jordan, M. P. (2000). Slow release HPMC matrix systems. Eur Pharm. Rev., 5(4), 21-23.
27. Roberts, M., Cespi, M., Ford, J. L., Dyas, A. M., Martini, G. L., & Crowley, P. J. (2006). The influence of ethanol on aspirin release from hypromellose matrix tablets. The British Pharmaceutical Conference & Exhibition, Manchester, UK.
28. Rodrigues, C. F., Bruneua, N., Barra, J., Alfonso, D., & Doelker, E. (2000). Hydrophilic cellulose derivatives as drug delivery carriers: Influence of substitution type on the properties of compressed matrix tablets. In D. L. Wise (Ed.), Handbook of pharmaceutical controlled release technology (pp. 1-30). New York: Marcel Dekker, Inc.
29. Rowe, R. C., Sheskey, P. J., & Weller, P. J. (Ed.) (2003). Handbook of pharmaceutical excipients (pp. 73, 109, 330, 610). London, UK: Pharmaceutical Press.
30. Sheu, M.-T., Chou, H. L., Kao, C.-C., Liu, C.-H., & Sokoloski, T.D. (1992). Dissolution of diclofenac sodium from matrix tablets. Int. J Pharm., 85, 57-63.
31. Tahara, K., Yamamoto, K., & Nishihata, T. (1995). Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose. J. Contr. Rel, 2910, 35, 59-66.
32. The United States Pharmacopeia (2004). Rockville, MD: The United States Pharmacopeial Convention, Inc., pp. 969, 778.
33. Velasco, M. V., Ford, J. L., Rowe, P., & Rajabi-Siahboomi, A. R. (1999). Influence of drug: hydroxypropyl methylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Contr. Rel., 57(1), 75-85.
34. Vuong, H., Levina, M., & Rajabi-Siahboomi, A. R. (2006). The influence of hydro-alcoholic media on hypromellose matrix systems. AAPS Annual Meeting and Exposition, San Antonio, TX, USA.
35. Wan, L. S. C., Heng, P. W. S., & Wong, L. F. (1995). Matrix swelling: a simple model describing extent of swelling of HPMC matrices. Int. J. Pharm., 116, 159-168.
36. Wilder, P. V., Detaevernier, M. R., & Michotte, Y. (1991). In vitro dissolution of two oral controlled release preparations of diclofenac sodium. Drug Dev. Ind. Pharm., 17, 141-148.